Identifying Rab2 Protein as a Key Interactor of Centrin1 Essential for Leishmania donovani Growth.

IF 4 2区 医学 Q2 CHEMISTRY, MEDICINAL
ACS Infectious Diseases Pub Date : 2024-09-13 Epub Date: 2024-08-07 DOI:10.1021/acsinfecdis.4c00351
Roshanara, Rati Tandon, Mirza Sarwar Baig, Sanchita Das, Rahul Srivastava, Niti Puri, Hira L Nakhasi, Angamuthu Selvapandiyan
{"title":"Identifying Rab2 Protein as a Key Interactor of Centrin1 Essential for <i>Leishmania donovani</i> Growth.","authors":"Roshanara, Rati Tandon, Mirza Sarwar Baig, Sanchita Das, Rahul Srivastava, Niti Puri, Hira L Nakhasi, Angamuthu Selvapandiyan","doi":"10.1021/acsinfecdis.4c00351","DOIUrl":null,"url":null,"abstract":"<p><p>Previously, we have demonstrated that deletion of a growth-regulating gene (<i>LdCen1</i>) in the <i>Leishmania donovani</i> parasite (<i>LdCen1</i><sup><i>-/-</i></sup>) attenuated the parasite's intracellular amastigote growth but not the growth of extracellular promastigotes. <i>LdCen1</i><sup><i>-/-</i></sup> parasites were found to be safe and efficacious against homologous and heterologous <i>Leishmania</i> species as a vaccine candidate in animal models. The reason for the differential growth of <i>LdCen1</i><sup><i>-/-</i></sup> between the two stages of the parasite needed investigation. Here, we report that <i>LdCen1</i> interacts with a novel Ras-associated binding protein in <i>L. donovani</i> (LdRab2) to compensate for the growth of <i>LdCen1</i><sup><i>-/-</i></sup> promastigotes. LdRab2 was isolated by protein pull-down from the parasite lysate, followed by nano-LC-MS/MS identification. The RAB domain sequence and the functional binding partners of the LdRab2 protein were predicted via Search Tool for the Retrieval of Interacting Proteins (STRING) analysis. The closeness of the LdRab2 protein to other reported centrin-binding proteins with different functions in other organisms was analyzed via phylogenetic analysis. Furthermore, <i>in vitro</i> and <i>in silico</i> analyses revealed that LdRab2 also interacts with other <i>L. donovani</i> centrins 3-5. Since centrin is a calcium-binding protein, we further investigated calcium-based interactions and found that the binding of LdRab2 to LdCen1 and LdCen4 is calcium-independent, whereas the interactions with LdCen3 and LdCen5 are calcium-dependent. The colocalization of LdCen1 and LdRab2 at the cellular basal-body region by immunofluorescence supports their possible functional association. The elevated expression of the LdRab2 protein in the mutant promastigotes suggested a probable role in compensating for the promastigote growth of this mutant strain, probably in association with other parasite centrins.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.4c00351","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Previously, we have demonstrated that deletion of a growth-regulating gene (LdCen1) in the Leishmania donovani parasite (LdCen1-/-) attenuated the parasite's intracellular amastigote growth but not the growth of extracellular promastigotes. LdCen1-/- parasites were found to be safe and efficacious against homologous and heterologous Leishmania species as a vaccine candidate in animal models. The reason for the differential growth of LdCen1-/- between the two stages of the parasite needed investigation. Here, we report that LdCen1 interacts with a novel Ras-associated binding protein in L. donovani (LdRab2) to compensate for the growth of LdCen1-/- promastigotes. LdRab2 was isolated by protein pull-down from the parasite lysate, followed by nano-LC-MS/MS identification. The RAB domain sequence and the functional binding partners of the LdRab2 protein were predicted via Search Tool for the Retrieval of Interacting Proteins (STRING) analysis. The closeness of the LdRab2 protein to other reported centrin-binding proteins with different functions in other organisms was analyzed via phylogenetic analysis. Furthermore, in vitro and in silico analyses revealed that LdRab2 also interacts with other L. donovani centrins 3-5. Since centrin is a calcium-binding protein, we further investigated calcium-based interactions and found that the binding of LdRab2 to LdCen1 and LdCen4 is calcium-independent, whereas the interactions with LdCen3 and LdCen5 are calcium-dependent. The colocalization of LdCen1 and LdRab2 at the cellular basal-body region by immunofluorescence supports their possible functional association. The elevated expression of the LdRab2 protein in the mutant promastigotes suggested a probable role in compensating for the promastigote growth of this mutant strain, probably in association with other parasite centrins.

Abstract Image

确定 Rab2 蛋白是对利什曼原虫生长至关重要的中心蛋白 1 的关键互作因子
此前,我们已经证明,在唐诺瓦利什曼病寄生虫(LdCen1-/-)中缺失一个生长调节基因(LdCen1)可减轻寄生虫细胞内非原体的生长,但不能抑制细胞外原原体的生长。作为候选疫苗,LdCen1-/-寄生虫在动物模型中对同源和异源利什曼原虫安全有效。我们需要研究 LdCen1-/- 寄生虫在两个阶段不同生长的原因。在这里,我们报告了 LdCen1 与一种新型 Ras 相关结合蛋白(LdRab2)相互作用,以补偿 LdCen1-/- 原虫的生长。从寄生虫裂解液中通过蛋白质牵引分离出 LdRab2,然后进行纳米液相色谱-质谱/质谱鉴定。通过检索相互作用蛋白搜索工具(STRING)分析预测了 LdRab2 蛋白的 RAB 结构域序列和功能结合伙伴。通过系统发育分析,分析了 LdRab2 蛋白与其他生物体中已报道的具有不同功能的中心蛋白结合蛋白的亲缘关系。此外,体外和硅学分析表明,LdRab2 还与其他唐诺沃尼氏菌中心蛋白 3-5 相互作用。由于中心蛋白是一种钙结合蛋白,我们进一步研究了基于钙的相互作用,发现 LdRab2 与 LdCen1 和 LdCen4 的结合不依赖于钙,而与 LdCen3 和 LdCen5 的相互作用依赖于钙。通过免疫荧光法,LdCen1 和 LdRab2 在细胞基底体区域的共定位支持了它们可能存在的功能性关联。LdRab2 蛋白在突变原虫中的高表达表明,它可能与其他寄生虫中心蛋白一起在补偿该突变株的原虫生长方面发挥作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Infectious Diseases
ACS Infectious Diseases CHEMISTRY, MEDICINALINFECTIOUS DISEASES&nb-INFECTIOUS DISEASES
CiteScore
9.70
自引率
3.80%
发文量
213
期刊介绍: ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to: * Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials. * Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets. * Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance. * Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents. * Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota. * Small molecule vaccine adjuvants for infectious disease. * Viral and bacterial biochemistry and molecular biology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信